Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-07-30
2000-04-04
Chang, Ceila
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514324, 514318, 546193, 546202, 5462811, A61K 3144, C07D40904
Patent
active
060462159
ABSTRACT:
This invention provides compounds and a method for the inhibition of serotonin reuptake in mammals.
REFERENCES:
patent: 3974280 (1976-08-01), Bernasconi
patent: 4195081 (1980-03-01), Nedelec et al.
patent: 4196209 (1980-04-01), Dumont et al.
patent: 4232031 (1980-11-01), Dument et al.
patent: 4278677 (1981-07-01), Nedelec et al.
patent: 4324790 (1982-04-01), Guillaume et al.
patent: 4333939 (1982-06-01), Guillaume et al.
patent: 5409940 (1995-04-01), Hulkenberg et al.
patent: 5521197 (1996-05-01), Audia
patent: 5532240 (1996-07-01), Nakao et al.
patent: 5576321 (1996-11-01), Krushinski, Jr. et al.
patent: 5714498 (1998-02-01), Kulagowski et al.
Abstract Doc. No. CPI C94-140025 (Japanese Patent JP 06234644 A, Aug. 23, 1994).
Malleron, J., J. Med. Chem. 1993, vol. 36, pp. 1194-1202.
Redrobe, J., Euro, J. Pharmacol., Dec. 30, 1996, vol. 318, pp. 213-220.
Chemical Abstracts, vol. 83 (19), abst. No. 163,998J, Nov. 10, 1975.
Audia James E.
Koch Daniel J.
Mabry Thomas E.
Nissen Jeffrey S.
Rocco Vincent P.
Chang Ceila
Eli Lilly and Company
Titus Robert D.
LandOfFree
Inhibition of serotonin reuptake does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibition of serotonin reuptake, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of serotonin reuptake will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-365614